Enrollment Milestone Achieved in MyPEAK™-1 and RIDGE™-1 Clinical Trials
August 6, 2025 - 23:19
Tenaya Therapeutics has announced significant progress in its clinical trials, marking a pivotal moment for its innovative therapies targeting specific heart conditions. The enrollment process for Cohorts 1 and 2 of the MyPEAK™-1 Phase 1b/2 trial of TN-201, aimed at treating MYBPC3-associated hypertrophic cardiomyopathy (HCM), has been successfully completed. This achievement has been bolstered by a positive safety review from the Data Safety Monitoring Board (DSMB), which has now allowed the company to proceed with the enrollment of expansion cohorts.
In addition, the RIDGE™-1 Phase 1b trial of TN-401 has also made strides, with Cohort 1 fully enrolled and the first patient with PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC) dosed in Cohort 2. This advancement follows the DSMB's recommendation to escalate dosing and expand the trial.
Tenaya Therapeutics is set to provide data readouts from both clinical programs in the fourth quarter of 2025, with a cash runway projected to extend into the second half of 2026, ensuring continued development of these promising therapies.
MORE NEWS
May 22, 2026 - 02:54
Q1 Earnings Outperformers: LPL Financial (NASDAQ:LPLA) And The Rest Of The Investment Banking & Brokerage StocksQuarterly earnings season offers a clear snapshot of how companies are navigating the current market, especially when stacked against direct competitors. In the investment banking and brokerage...
May 21, 2026 - 18:31
Stock market today: Dow clinches record high, S&P 500 and Nasdaq rise as stocks rebound on US-Iran peace hopesWall Street closed higher on Tuesday, with the Dow Jones Industrial Average securing a new record high, while the S&P 500 and Nasdaq also posted gains. The broad market rally was fueled by renewed...
May 21, 2026 - 08:48
Greek finance minister hails troika reforms as ‘absolutely necessary’Greece`s finance minister, Kyriakos Pierrakakis, has described the strict reforms imposed by international creditors more than a decade ago as `absolutely necessary` for the country`s current...
May 20, 2026 - 23:59
NVIDIA Announces Financial Results for First Quarter Fiscal 2027NVIDIA has announced its financial results for the first quarter of fiscal 2027, posting record revenue of $81.6 billion. That figure marks an 85 percent jump compared to the same period a year ago...